SCHEMBL10141557

SCHEMBL10141557

CC(C)c1cnn(Cc2cncn2C)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 5/20 0.38
CHRM5 P08912 3/20 0.33
CHRM4 P08173 2/20 0.31
CHRM1 P11229 2/20 0.31
CYP2C9 P11712 2/20 0.31
CHRM3 P20309 2/20 0.31
LMNA P02545 2/20 0.31
CHRM2 P08172 1/20 0.31
CYP2A6 P11509 1/20 0.31
CNR1 P21554 1/20 0.31
HTR2A P28223 1/20 0.31
CYP2A13 Q16696 1/20 0.31
MEN1 O00255 1/20 0.31
USP2 O75604 1/20 0.31
TP53 P04637 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
ALOX15 P16050 1/20 0.31
ALOX12 P18054 1/20 0.31
NFKB1 P19838 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10141538 0.81 KCNH2 (0.58) KCNH2
SCHEMBL15033943 0.80 KCNH2 (0.40) KCNH2CHRM5CHRM4CHRM1CYP2C9
SCHEMBL4221568 0.73 L3MBTL1 (0.41) KCNH2LMNACYP3A4CYP2C19KDM4E
SCHEMBL10141539 0.71 CYP2C9 (0.42) KCNH2CYP2C9CYP2C19
SCHEMBL10141558 0.70 CYP19A1 (0.43) LMNAMEN1TP53KMT2AKDM4E
SCHEMBL18471507 0.70 CYP3A4 (0.47) KCNH2CYP2C9LMNACYP3A4MAPK1
SCHEMBL27364317 0.70 ALDH1A1 (0.36)
SCHEMBL10100351 0.70 L3MBTL1 (0.50) MAPK1KMT2AMAPT
SCHEMBL9583722 0.69 MEN1 (0.48) CHRM5CHRM4CHRM1CYP2C9CHRM3
SCHEMBL1619043 0.69 KMT2A (0.40) LMNAMEN1CYP2C19KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170260175-A1 ISOINDOLINONE INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE VERTEX PHARMACEUTICALS INCORPORATED 2017-09-14 US disclosed
US-9676759-B2 Isoindolinone inhibitors of phosphatidylinositol 3-kinase VERTEX PHARMACEUTICALS INCORPORATED (US) 2017-06-13 US disclosed
US-20140038936-A1 ISOINDOLINONE INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE VERTEX PHARMACEUTICALS INCORPORATED 2014-02-06 US disclosed
US-8466288-B2 Isoindolinone inhibitors of phosphatidylinositol 3-kinase VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-06-18 US disclosed
US-20120202784-A1 ISOINDOLINONE INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-08-09 US disclosed
US-20120040950-A1 ISOINDOLINONE INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140038936-A1 ISOINDOLINONE INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE PIK3CD, PIK3CA, PIK3R5 KCNH2 3395/4885CHRM5 4848/4885CHRM4 4867/4885
US-20120040950-A1 ISOINDOLINONE INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE PIK3CD, PIK3CA, PIK3R5 KCNH2 3395/4885CHRM5 4848/4885CHRM4 4867/4885
US-20120202784-A1 ISOINDOLINONE INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE PIK3CD, PIK3CA, PIK3R5 KCNH2 3395/4885CHRM5 4848/4885CHRM4 4867/4885
US-20170260175-A1 ISOINDOLINONE INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE PIK3CD, PIK3CA, PIK3R5 KCNH2 3395/4885CHRM5 4848/4885CHRM4 4867/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.